Biolase Inc (BIOL):企業の財務・戦略的SWOT分析

◆英語タイトル:Biolase Inc (BIOL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME81FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biolase Inc (BIOL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. The company offers two categories of laser systems: WaterLase all tissue laser systems and Diode soft tissue laser systems. The Waterlase laser system product includes Waterlase Express, Waterlase iPlus and Waterlase MD and MDX; Diode system product includes e Epic Hygiene, Epic Pro, Epic X and Epic 10. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontist, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance services. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.

Biolase Inc Key Recent Developments

Nov 12,2020: BIOLASE reports strong sequential revenue growth in third quarter 2020
Oct 14,2020: BIOLASE announces preliminary third quarter revenue results; reopening of dental practices drives sequential revenue growth
Aug 13,2020: BIOLASE reports second quarter 2020 financial results
Jul 13,2020: Landmark Head-to-Head study published in Journal of Periodontology concludes that BIOLASE REPAIR Perio Protocol is superior for procedure time and patient-reported outcomes
May 07,2020: BIOLASE reports first quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Biolase Inc – Key Facts
Biolase Inc – Key Employees
Biolase Inc – Key Employee Biographies
Biolase Inc – Major Products and Services
Biolase Inc – History
Biolase Inc – Company Statement
Biolase Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Biolase Inc – Business Description
Business Segment: Consumables and other
Overview
Performance
Business Segment: Imaging systems
Performance
Business Segment: Laser Systems
Overview
Performance
Key Stats
Business Segment: License fees and royalties
Overview
Performance
Business Segment: Services
Overview
Performance
Geographical Segment: International
Performance
Geographical Segment: The US
Performance
R&D Overview
Biolase Inc – Corporate Strategy
Biolase Inc – SWOT Analysis
SWOT Analysis – Overview
Biolase Inc – Strengths
Biolase Inc – Weaknesses
Biolase Inc – Opportunities
Biolase Inc – Threats
Biolase Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Biolase Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Biolase Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Biolase Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2020: BIOLASE reports strong sequential revenue growth in third quarter 2020
Oct 14, 2020: BIOLASE announces preliminary third quarter revenue results; reopening of dental practices drives sequential revenue growth
Aug 13, 2020: BIOLASE reports second quarter 2020 financial results
Jul 13, 2020: Landmark Head-to-Head study published in Journal of Periodontology concludes that BIOLASE REPAIR Perio Protocol is superior for procedure time and patient-reported outcomes
May 07, 2020: BIOLASE reports first quarter 2020 financial results
Apr 14, 2020: Biolase receives loan under Paycheck Protection Program
Mar 26, 2020: BIOLASE reports 2019 fourth quarter; net revenue increased 18% sequentially
Nov 15, 2019: BIOLASE appoints Michael DiTolla, DDS, FAGD to its Board Of Directors
Nov 06, 2019: BIOLASE reports third quarter 2019 results
Oct 23, 2019: BIOLASE wraps inaugural advancing dentistry symposium
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Biolase Inc, Key Facts
Biolase Inc, Key Employees
Biolase Inc, Key Employee Biographies
Biolase Inc, Major Products and Services
Biolase Inc, History
Biolase Inc, Subsidiaries
Biolase Inc, Key Competitors
Biolase Inc, Ratios based on current share price
Biolase Inc, Annual Ratios
Biolase Inc, Annual Ratios (Cont...1)
Biolase Inc, Interim Ratios
Biolase Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Biolase Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Biolase Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Biolase Inc (BIOL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sembcorp Industries Ltd (U96):電力:M&Aディール及び事業提携情報
    Summary Sembcorp Industries Ltd (Sembcorp) is a diversified energy, water and marine company. It provides solutions across the energy and utilities value chain, with a focus on gas and power, renewables and environment, and merchant and retail sectors. The company carries out production and supply o …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • MetGen Oy-製薬・医療分野:企業M&A・提携分析
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company provides metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosi …
  • Curtiss-Wright Corporation (CW)-石油・ガス分野:企業M&A・提携分析
    Summary Curtiss-Wright Corporation (Curtiss-Wright) is a diversified industrial company. It designs, manufactures and overhauls precision components and provides highly engineered and critical-function products, systems and services. Its offerings include sensor handling systems, surface technology …
  • Belfius Bank Sa:企業の戦略・SWOT・財務分析
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • C. Uyemura & Co., Ltd. (4966):企業の財務・戦略的SWOT分析
    C. Uyemura & Co., Ltd. (4966) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Dongkook Pharmaceutical Co Ltd (086450)-製薬・医療分野:企業M&A・提携分析
    Summary Dongkook Pharmaceutical Co Ltd (Dongkook) formerly known as UEC & Co. Ltd, is a pharmaceutical company which develops, manufacture and distributes pharmaceutical products, health care products and medical devices. It offers pharmaceutical products such as antibiotics, anodynes, vitamins, wou …
  • InVivoScribe Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. It also provides general purpose reagents such as PCR …
  • Metsa Tissue Corporation:企業の戦略的SWOT分析
    Metsa Tissue Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SPI Energy Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Spi Energy Co Ltd (Spi Energy), formerly Solar Power Inc, is a photovoltaic (PV) solutions provider. The company offers development, financing, installation, operation and sale of utility-scale and residential solar power projects. It also operates online energy e-commerce and investment pla …
  • Kwality Group
    Kwality Group - Strategy, SWOT and Corporate Finance Report Summary Kwality Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BUCA, Inc.:企業の戦略・SWOT・財務情報
    BUCA, Inc. - Strategy, SWOT and Corporate Finance Report Summary BUCA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. …
  • GlobalData plc (PRO):企業の財務・戦略的SWOT分析
    Summary GlobalData Plc (GD), formerly Progressive Digital Media Group Plc, is a provider of data insights, analytics and information services. The company’s solutions encompass market and competitive analysis, strategic planning, mergers and acquisitions, financial decisions, legal and accounting, m …
  • Source BioScience Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Source Bioscience Ltd (Source BioScience), a subsidiary of Sherwood Holdings Ltd is a provider of laboratory products and services. The company offers life science research, clinical product, and controlled environment products. Its life science research products include antibodies, clones, …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hyundai Motor Co (005380)-エネルギー分野:企業M&A・提携分析
    Summary Hyundai Motor Company (Hyundai) is a global manufacturer of automobiles, which designs, develops and manufactures passenger and heavy duty automobiles and relevant parts. The company manufactures passenger cars under various brand names such as Centennial, Genesis, Veloster, Azera, Sonata, i …
  • Boral Limited:企業のM&A・事業提携・投資動向
    Boral Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boral Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆